Clindamycin 150 mg/mL (Clindamycin Phosphate INJECTION, SOLUTION) 150 mg/mL

Clindamycin 150 mg/mL is an injectable solution used for various bacterial infections. This single-dose vial is suitable for intramuscular or intravenous administration.

Strength

150 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 BAG (0404-9838-06) / 6 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Henry Schein, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clindamycin 150 mg/mL is commonly used to treat bacterial infections. It is effective against a range of bacterial strains, making it a versatile option for what is Clindamycin used for. This medication is often prescribed for infections that respond to Clindamycin phosphate, including skin, soft tissue, and respiratory infections.

Side Effects

Common effects of Clindamycin 150 mg/mL may include mild to moderate pain at the injection site. Some users might experience gastrointestinal discomfort. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Precautions & Warnings

Clindamycin 150 mg/mL should be handled with care to avoid contamination. It is important to follow proper injection techniques and dispose of the vial safely. Always consult a healthcare provider before use, especially if you have a history of allergic reactions to similar medications.

Avoid Interactions

Clindamycin 150 mg/mL may interact with other medications, including muscle relaxants and certain antibiotics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.

Frequently Asked Questions

Clindamycin 150 mg/mL is used to treat bacterial infections, including skin, soft tissue, and respiratory infections.

Clindamycin 150 mg/mL can be administered intramuscularly or intravenously, following proper injection techniques.

Common side effects may include pain at the injection site and gastrointestinal discomfort.

Yes, Clindamycin 150 mg/mL may interact with muscle relaxants and certain antibiotics. Consult a healthcare provider for specific interactions.

Clindamycin is also available in oral forms, but this specific product is an injectable solution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.